Intracellular trafficking of factor VIII to von Willebrand factor storage granules

Journal of Clinical Investigation

Volumn 101, Issue 3, 1998, Pages 613-624

  Rosenberg, Jonathan B ^a   Foster, Paul A ^a,b   Kaufman, Randal J ^c   Vokac, Elizabeth A ^a   Moussalli, Micheline ^c   Kroner, Philip A ^a   Montgomery, Robert R ^a,b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Carrier proteins; Hemophilia A; Molecular chaperones; Protein sorting; Vascular endothelium

Indexed keywords

BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ANIMAL CELL; ARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE MUTATION; GOLGI COMPLEX; HEMATOPOIETIC CELL; HEMOPHILIA A; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; STEM CELL TRANSPLANTATION; TARGET CELL; VASCULAR ENDOTHELIUM;

EID: 0032007271     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1250     Document Type: Article

References (57)

1. Mannucci, P.M. 1988. Desmopressin: a nontransfusional form of trcalment for congenital and acquired bleeding disorders. Blood. 72:1449-1455.
2. Montgomery, R.R., and B.S. Coller. 1994. von Willebrand disease. In He-mostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd ed. R.W. Colman. J. Hirsh, V.J. Marder, and E.W. Salzman, editors. J.B. Lippincott Co., Philadelphia. 156-157.
3. Hashemi, S., E.S. Tackaberry, D.S. Palmer, G. Rock, and P.R. Ganz. 1990. DDAVP-induced release of von Willehrand factor from endothelial cells in vitro: the effect ol plasma and blood cells. Biochim. Biophys. Acta. 1052:63-70.
4. Casonato, A.. D. Dannhauser, E. Ponlara, A. Bertomoro, B. Orazi, P. Zerbinati, and A. Girolami. 1996. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor. Blood Coagul. Fibrinolysis. 7:549-553.
5. Lethagen, S. 1994. Desmopressin (DDAVP) and hemostasis. Ann. Hematol. 69:173-180.
6. Mannucci, P.M., M.T. Canciani, L. Rota, and B.S. Donovan. 1981. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with hemophilia and von Willebrand's disease. Br. J. Haematol. 47: 283-293.
7. Caltaneo, M., L. Simoni, A. Gringeri, and P.M. Mannucci. 1994. Patients with severe von Willebrand disease are sensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor. Br. J. Haematol. 86:333-337.
8. Kadhom, N., C. Wolfrom, M. Gautier, J.P. Allain, and D. Frommel. 1988. Factor VIII procoagulant antigen in human tissues. Thromb. Haemostasis. 59: 289-294.
9. Belloni, P.N., D.H. Carney, and G.L. Nicolson. 1992. Organ-derived microvessel endothelial cells exhibit differential responsiveness to thirombin and other growth factors. Microvasc. Res. 43:20-45.
10. Wagner, D.D., J.B. Olmsted, and V.J. Marder. 1982. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J. Cell Biol. 95:355-360.
11. D'Angelo, A., A. Capitanio, J.B. Smith, C. Valsecchi, and P.M. Mannucci. 1983. Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products. Thromb. Haemostasia. 49:64-65.
12. Takeuchi, M., H. Nagura, and T. Kaneda. 1988. DDAVP and epinephrine-induced changes in the localization of von Willebrand factor antigen in endothelial cells of human oral mucosa. Blood. 72:850-854.
13. Meyer. D., and J.-P. Girma, 1993. von Willebrand factor: structure and function. Thromb. Haemostasis. 70:99-104.
14. Wagner, D.D. 1990. Cell biology of von Willebrand factor. Annu. Rev. Cell Biol. 6:217-246.
15. Halban, P.A., and J.-C. Irminger. 1994. Sorting and processing of secretory proteins. Biochem. J. 299:1-18.
16. Burgess, T.L., and R.B. Kelly. 1987. Constitutive and regulated secretion of proteins. Ann. Rev. Cell Biol. 3:243-293.
17. Sporn, L.A., V.J. Marder, and D.D. Wagner. 1989. Differing polarity of the constitutive and regulated secretory pathways for von Willebrand faclor in endothelial cells. J. Cell Biol. 108:1283-1289.
18. Sporn, L.A., V.J. Marder, and D.D. Wagner. 1987. von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively. Blood. 69:1531-1534.
19. Ginsburg, D., and J.E. Sadler. 1993. von Willebrand disease: a database of point mutations, insertions, and deletions. Thromb. Haemostasis. 69:177-184.
20. Kroner, P.A., K.D. Friedman, S.A. Fahs, J.P. Scott, and R.R. Montgomery. 1991. Abnormal binding of Factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease. J. Biol. Chem. 266:19146-19149.
21. Kaufman, R.J. 1992. Biological regulation of factor VIII activity. Ann. Rev. Med. 43:325-339.
22. Wion, K.L., D. Kelly, J.A. Summerfield, E.G.D. Tuddenham, and R.M. Lawn. 1985. Distribution of human VIII mRNA and antigen in human liver and other tissues. Nature. 317:726-728.
23. Zelechowska, M.G., J.A. van Mourik, and T. Brodniewicz-Proba. 1985. Ultraslructural localization of faclor VIII procoagulant antigen in human liver hepatocytes. Nature. 317:729-730.
24. Webster, W.P., C.F. Zukoski, P. Hutchin, R.L. Reddick, S.R. Mandel, and G.P. Penick. 1971. Plasma factor VIII synthesis and control as revealed by canine organ transplantation. Am. J. Physiol. 220:1147-1154.
25. Groth, C.G., W.E. Hathaway, A. Gustafsson, W.P. Geis, C.W. Putnam, C. Bjorken, K. A. Porter, and T.E. Starzl. 1974. Correction of coagulation in the hemophilic dog by transplantation of lymphatic tissue. Surgery. 75:725-733.
26. Eewis, J.H., F.A. Bontempo, J.A. Spero, M.V. Ragni, and T.E. Starzl. 1985. Liver transplantation in a hemophiliac. N. Engl. J. Med. 312:1189-1190.
27. Bontempo, F.A., J.H. Lewis, T.J. Gorene, J.A. Spero, M.V. Ragni, J.P. Scott, and T.E. Starzl. 1987. Liver transplantation in hemophilia A. Blood. 69: 1721-1724.
28. Liu, L., S. Xia, and J. Seifert. 1994. Transplantation of spleen cells in patients with hemophilia A. Transplant. Int. 7:201-206.
29. Pittman, D.D., M. Milleson, K. Marquette, K. Bauer, and R.J. Kaufman. 1992. A2 domain of human recombinant-derived Factor VIII is required for procoagulanl activity but not for thrombin cleavage. Blood. 79:389-397.
30. pittman, D.D., K.A. Marquette, and R.J. Kaufman. 1994. Role of the B domain for factor VIII and factor V expression and function. Blood. 84:4214-4225.
31. Kaufman, R.J., L.C. Wasley, and A.J. Dorner. 1988. Synthesis, processing, and secretion of recombinant human Factor VIII expressed in mammalian cells. J. Biol. Chem. 263:6352-6362.
32. Kroner, P.A., P.A. Foster, S.A. Fahs, and R.R. Montgomery. 1996. The defective interaction between von Willebrand factor and Factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg 19 and His54 in mature von Willebrand factor. Blood. 87:1013-1021.
33. Moore, H.-P.H., M.D. Walker, F. Lee, and R.B. Kelly. 1983. Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proleolytic processing, and secretion on stimulation. Cell. 35:531-538.
34. Dorner, A.J., L.C. Wasley, and R.J. Kaufman. 1989. Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells. J. Biol. Chem. 264:20602-20607.
35. Wagner, D.D., S. Saffaripour, R. Bonfanti, J.E. Sadler, E.M. Cramer, B. Chapman, and T.N. Mayadas. 1991. Induction of specific storage organelles by von Willebrand factor propolypeptide. Cell. 64:403-413.
36. Scott, J.P., and R.R. Montgomery. 1991. The rapid differentiation of type IIb vWd from platelet-type (pseudo-) vWd by the "neutral" monoclonal antibody binding assay. Am. J. Clin. Pathol. 96:723-725.
37. Nishino, M., J.P. Girma, C. Rothschild, E. Fressinaud, and D. Meyer. 1989. New variant of von Willebrand disease with defective binding to factor VIII. Blood. 74:1591-1599.
38. Dorner, A.J., and R.J. Kaufman. 1990. Analysis of synthesis, processing, and secretion of proteins expressed in mammalian cells. Methods Enzymol. 185: 577-596.
39. Vischer, U.M., and D.D. Wagner. 1994. von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood. 83:3536-3544.
40. Hattori, R., K.K. Hamilton, R.D. Fugates, R.P. McEver, and P.J. Sims. 1989. Stimulated secretion of endotheliai von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J. Biol. Chem. 264:7768-7771.
41. Dorner, A.J., L.C. Wasley, and R.J. Kaufman. 1992. Overexpression of GRP78 mitigates stress induction of glucose regulated proteins and blocks secretion of selective proteins in Chinese hamster ovary cells. EMBO (Eur. Mol. Biol. Organ.) J. 4:1563-1571.
42. Fallaux, F.J., R.C. Hoeben, S.J. Cramer, D.J.M. van der Wollenberg, E. Briet, H. van Ormondt, and A.J. van der Eb. 1996. The human clotting factor FVIII cDNA contains an autonomously replicating sequence consensus- and matrix attachment region-like sequence that binds a nuclear factor, represses heterologous gene expression, and mediates the transcriptional effects of sodium butyrate. Mol. Cell Biol. 16:4264-4272.
43. Piuman, D.D., E.M. Alderman, K.N. Tomkinson, J.H. Wang, A.R. Giles, and R.J. Kaufman. 1993. Biochemical. immunological, and in vivo functional characterization of B-domain-deleted Factor VIII. Blood. 81:2925-2935.
44. Journet, A.M., S. Saffaripour, E.M. Cramer, D. Tenza, and D.D. Wagner. 1993. von Willebrand factor storage requires intact prosequence cleavage site. Eur. J. Cell Biol. 60:31-41.
45. Hop, C., R. Fontijn, J.A. van Mourik, and H. Pannekoek. 1997. Polarity of constitutive and regulated von Willebrand factor secretion by transfected MDCK-II cells. Exp. Cell Res. 230:352-361.
46. Voorberg, J., R. Fontijn, J. Calafat, H. Janssen, J.A. van Mourik, and H. Pannekoek. 1993. Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells. EMBO (Eur. Mol. Biol. Organ.) J. 12: 749-758.
47. Sedlak, B.J., F.M. Booyse, S. Bell, and M.F. Rafelson, Jr. 1976. Comparison of two types of endothelial cells in long term culture. Thromb. Haemostasis. 35:167-177.
48. Burgess, T.L., C.S. Craik, and R.B. Kelly. 1985. The exocrine protein trypsinogen is targeted into the secretory granules of an endocrine cell line: studies by gene transfer. J. Cell Biol. 101:639-645.
49. Kaufman, R.J., L.C. Wasley, M.V. Davies, R.J. Wise, D.I. Israel, and A.J. Dorner. 1989. Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Mol Cell. Biol. 9:1233-1242.
50. Menache, D., D.L. Aronson, F. Darr, R.R. Montgomery, J.C. Gill, C.M. Kessler, J.M. Lusher, P.D. Phatak, A.D. Shapiro, A.R. Thompson, and G.C. White II. 1996. Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Br. J. Haematol. 94:740-745.
51. Mazurier, C., and D. Meyer. 1996. Factor VIII binding assay of von Willebrand factor and diagnosis of type 2N von Willebrand disease: results of an international survey. Thromb. Haemostasis. 76:270-274.
52. Kroner, P.A., P.A. Foster, S.A. Fahs, and R.R. Montgomery. 1993. Persistence of pro-vWF, an inherited cause of reduced factor VIII binding, and its comparison with other factor VIII binding vWF mutants. Thromb. Haemostasis. 69:1212a. (Abstr.)
53. Vischer, U.M., and D.D. Wagner. 1994. von Wilebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood. 83:3536-3544.
54. Wagner, D.D., P.J. Fay, L.A. Sporn, S. Sinha, S.O. Lawrence, and V.J. Marder. 1987. Divergent fates of von Willebrand factor and its propolypeptide (von. Willebrand antigen II) after secretion from endothelial cells. Proc. Natl. Acad. Sci. USA. 84:1955-1954.
55. Wise, R.J., A.J. Dorner, M. Krane, D.D. Pittman, and R.J. Kaufman. 1991. The role of von Willebrand factor multimers and propeptide cleavage in the binding and stabilization of facior VIII. J. Biol. Chem. 266:21948-21955.
56. Michnick, D.A., D.D. Pittman, R.J. Wise, and R.J. Kaufman. 1994. Identification of individual tyrosine sulfation sites within Factor VIII required for optimal activity and efficient thrombin cleavage. J. Biol. Chem. 269:20095-20102.
57. Wagner, D.D. 1993. The Weibel-Palade body: the storage granule for von Willebrand factor and P-selectin. Thromb. Haemostasis. 70:105-110.